Schedule a Liver Evaluation
Seek care for fatty liver on imaging, persistent liver-enzyme elevation, type 2 diabetes with liver risk, or an indeterminate or high FIB-4.
- Bring laboratory trends
- Include prior imaging
Why Choose GastroDoxs for Nonalcoholic Steatohepatitis Care?
Treatment-stage care connects the diagnosis with practical options, safety review, monitoring, and specialist coordination.
Fibrosis-First Treatment Planning
We use FIB-4, platelets, elastography, imaging, and clinical findings to determine whether the liver is low risk, needs closer monitoring, or has advanced fibrosis.
- Noninvasive liver staging
- Specialist referral when risk is elevated
Weight and Metabolic Care
We coordinate nutrition, activity, medical weight treatment, diabetes control, cholesterol care, and blood-pressure management.
- Sustainable weight reduction
- Diabetes and lipid management
MASH Medication Eligibility
We review whether current FDA-approved treatment may be appropriate for an adult with noncirrhotic MASH and F2-F3 fibrosis.
- Resmetirom eligibility review
- Semaglutide eligibility review
Long-Term Liver Monitoring
We track liver tests, metabolic health, fibrosis measures, symptoms, and treatment response.
- Repeat fibrosis assessment
- Cirrhosis surveillance when needed
What Happens After You Book a Nonalcoholic Steatohepatitis Visit?
A clear path from scheduling and records review to a personalized treatment plan.
Tell Us What Is Happening
Share your current nonalcoholic steatohepatitis symptoms, diagnosis, treatment history, goals, and the questions you need answered.
Upload or Bring Your Records
Bring liver-test trends, platelets, FIB-4 results, FibroScan or MR elastography, ultrasound or MRI, diabetes and cholesterol records, medication and supplement list, alcohol history, and previous weight-treatment details.
Receive a Specialist Treatment Review
A GastroDoxs GI specialist reviews the diagnosis, treatment options, safety factors, expected benefits, and whether another specialist or procedure is needed.
Leave With Defined Next Steps
Your nonalcoholic steatohepatitis plan may include medication, nutrition, lifestyle care, testing, a procedure, monitoring, or coordinated referral.
GastroDoxs GutGuardians™
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
GastroDoxs GutRescue Mission™
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Who May Benefit From a Nonalcoholic Steatohepatitis Treatment Visit?
Schedule non-emergency care when you need treatment selection, reassessment, monitoring, or specialist coordination.
You Need Help Choosing Weight and Metabolic Treatment
Sustained weight reduction, nutrition care, physical activity, diabetes control, cholesterol treatment, and blood-pressure care reduce metabolic and liver risk.
- Treat cardiovascular risk
- Protect muscle during weight loss
Liver Risk Is Not Improving
Schedule review when liver stiffness, platelets, liver tests, diabetes, weight, or metabolic risk worsens despite the current plan.
- Review adherence and treatment response
- Check for another cause or complication
You Need Monitoring or Advanced Care
Selected patients without decompensated cirrhosis may benefit from medical, endoscopic, or surgical weight treatment.
- Assess liver stage before procedures
- Continue long-term metabolic follow-up
Nonalcoholic Steatohepatitis Care With GastroDoxs GI Specialists
MASH treatment should be guided by fibrosis stage, metabolic health, current FDA-approved therapy eligibility, treatment safety, cardiovascular risk, and long-term liver monitoring.
What Patients Can Expect From Nonalcoholic Steatohepatitis Care
GastroDoxs Treatment Guidance for Nonalcoholic Steatohepatitis
GastroDoxs provides patient-facing treatment planning for nonalcoholic steatohepatitis, including records review, medication and procedure questions, symptom monitoring, insurance guidance, and coordinated referral when another specialist is needed.
All locations accept most major insurance — Aetna, BCBS, Cigna, UnitedHealthcare, Medicare.
Book an Appointment →
Have Questions Before Booking Nonalcoholic Steatohepatitis Care?
Effective treatment targets both liver fibrosis and metabolic risk. Options include sustained weight reduction, physical activity, diabetes and cholesterol care, and FDA-approved therapy such as resmetirom or semaglutide for eligible adults with noncirrhotic MASH and moderate-to-advanced fibrosis.
MASH can improve and sometimes resolve when metabolic risk and inflammation are controlled, especially before cirrhosis develops. Established advanced fibrosis may regress in some patients, but cirrhosis requires lifelong monitoring.
A sustained 5% weight reduction can improve liver fat, while about 7% to 10% or more may provide greater improvement in inflammation and fibrosis. The safest target should protect muscle and nutrition.
A Mediterranean-style pattern rich in vegetables, fruit, whole grains, legumes, nuts, fish, and unsaturated fats is commonly recommended. The plan should support gradual weight reduction, diabetes control, and adequate protein.
Limit sugar-sweetened drinks, excess refined carbohydrates, highly processed foods, large amounts of saturated fat, and alcohol. Patients with advanced fibrosis or cirrhosis should discuss alcohol avoidance with their liver specialist.
Yes. Resmetirom and semaglutide are FDA-approved for eligible adults with noncirrhotic MASH and moderate-to-advanced fibrosis. Selection requires fibrosis confirmation, medication review, safety assessment, and specialist monitoring.
Aerobic and resistance exercise reduce liver fat, improve insulin sensitivity, support cardiovascular health, and help preserve muscle. Benefit can occur even before major weight loss appears.
Yes. Improving diabetes, obesity, cholesterol, blood pressure, and sleep apnea reduces metabolic stress on the liver and lowers cardiovascular risk. These conditions should be treated alongside liver-specific care.
Doctors combine fibrosis stage, weight, diabetes, cholesterol, blood pressure, alcohol and medicine history, liver tests, imaging, treatment eligibility, muscle risk, and patient preferences.
Warning signs include worsening liver stiffness, falling platelets, rising bilirubin, increasing swelling, muscle loss, confusion, or continued metabolic deterioration. Symptoms alone may not show whether fibrosis is progressing.
Liver fat and enzymes may improve within months, while fibrosis improvement usually takes longer. Monitoring intervals depend on baseline risk, treatment type, metabolic control, and noninvasive test results.
Effective treatment can lower the risk of fibrosis progression and cirrhosis, especially when started before advanced disease. No treatment eliminates all risk, so fibrosis monitoring must continue.
Advanced therapy should be considered when noninvasive testing or biopsy confirms F2-F3 fibrosis, metabolic risk remains high, or lifestyle and standard medical care have not adequately controlled disease.
Doctors monitor liver tests, platelets, weight, glucose, cholesterol, medication safety, FIB-4, elastography, and symptoms. Patients with cirrhosis also need liver-cancer surveillance and complication screening.
The greatest long-term benefits come from sustained weight and metabolic treatment, regular aerobic and resistance activity, a high-quality eating pattern, limited alcohol, medication adherence, and scheduled fibrosis monitoring.
Book a Nonalcoholic Steatohepatitis Treatment Visit
Book a GastroDoxs MASH treatment visit for elevated fibrosis risk, weight and metabolic planning, medication eligibility, elastography follow-up, or cirrhosis prevention.